Back
Novo Nordisk AS Vs. Genfit SA Industry Stock Comparison
Sell
39
NVO
Novo Nordisk AS
Last Price:
111.96
Seasonality Move:
7.41%
Buy
68
GNFT
Genfit SA
Last Price:
5.75
Seasonality Move:
23.17%
Sell
39
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $113.24. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Genfit SA (GNFT)
is a Buy
Is Genfit SA a Buy, Sell or Hold?
- The current Genfit SA [GNFT] share price is $5.84. The Score for GNFT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GNFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $113.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GNFT Stock Price Chart
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.33 | Sell |
| Relative Strength Index (14 RSI): | 33.23 | Sell |
| Chaikin Money Flow: | 9284762 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.98 - 120.7) | Sell |
| Bollinger Bands (100): | (121.55 - 140.81) | Sell |
GNFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 57.36 | Buy |
| Chaikin Money Flow: | 2461 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.36 - 5.96) | Buy |
| Bollinger Bands (100): | (3.93 - 5.31) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 114.3 | Sell |
| 20-day SMA: | 116.22 | Sell |
| 50-day SMA: | 125.51 | Sell |
| 200-day SMA: | 128.16 | Sell |
| 8-day EMA: | 114.13 | Sell |
| 20-day EMA: | 117.02 | Sell |
| 50-day EMA: | 122.76 | Sell |
| 200-day EMA: | 123.17 | Sell |
GNFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.7 | Buy |
| 20-day SMA: | 5.69 | Buy |
| 50-day SMA: | 4.99 | Buy |
| 200-day SMA: | 4.21 | Buy |
| 8-day EMA: | 5.69 | Buy |
| 20-day EMA: | 5.6 | Buy |
| 50-day EMA: | 5.18 | Buy |
| 200-day EMA: | 4.41 | Buy |
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.79 per share.
Genfit SA Earnings Growth & GNFT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and a decrease next year of $1.55 per share.
Novo Nordisk AS Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Genfit SA Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||